Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 927,231 | reported | 31 Jan 2023 | tx 18+938,807 |
| RAPT Therapeutics, Inc. | 625 | reported | 27 Sept 2021 | tx 23+6,758,890−36,631,411 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 176,730 | 5.00 USD | |
| 30 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 7,542 | 5.00 USD | |
| 27 Oct 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 76,877 | 4.86 USD | |
| 26 Oct 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 72,774 | 4.85 USD | |
| 25 Oct 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 51,046 | 4.75 USD | |
| 16 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 1,094 | 12.90 USD | |
| 16 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 32,072 | 12.90 USD | |
| 13 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 125,096 | — | |
| 13 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 4,269 | — | first after silence |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 625 | 19.30 USD | |
| 27 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 1,114 | 34.97 USD | |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 1,114 | 22.20 USD | |
| 27 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 7,500 | 34.48 USD | |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 7,500 | 28.27 USD | |
| 27 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 625 | 34.94 USD | |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 625 | 0.00 USD | deriv |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 1,114 | 0.00 USD | deriv |
| 27 Sept 2021 | EXERCISE | RAPT Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 18 Jun 2020 | OTHER | RAPT Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 25 Mar 2020 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,416 | 12.49 USD | |
| 23 Mar 2020 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 170,387 | 11.63 USD | |
| 24 Mar 2020 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 128,377 | 12.22 USD | |
| 04 Nov 2019 | CONVERSION | RAPT Therapeutics, Inc. | 727,008 | — | |
| 04 Nov 2019 | CONVERSION | RAPT Therapeutics, Inc. | 1,454,016 | — | |
| 04 Nov 2019 | CONVERSION | RAPT Therapeutics, Inc. | 145,401 | — |
1 purchase reported after at least 12 months of silence — most recent on 13 May 2022.